Levels of 4-aminobiphenyl-induced somatic H-ras mutation in mouse liver DNA correlate with potential for liver tumor development

Molecular Carcinogenesis

Volumn 42, Issue 4, 2005, Pages 193-201

  Parsons, Barbara L ^a   Beland, Frederick A ^a   Von Tungeln, Linda S ^a   Delongchamp, Robert R ^a   Fu, Peter P ^a   Heflich, Robert H ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Biomarker; Carcinogenesis; Oncogene; Point mutation; Ras; Risk assessment

Indexed keywords

4 BIPHENYLAMINE; CARCINOGEN; DIMETHYL SULFOXIDE; DNA;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GENETICS; CANCER RISK; CODON; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DNA ADDUCT; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC SUSCEPTIBILITY; INDUCED MUTATION; LIVER CARCINOGENESIS; MALE; MOUSE; MUTAGENESIS; MUTATIONAL ANALYSIS; NONHUMAN; ONCOGENE H RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SOMATIC MUTATION;

AMINOBIPHENYL COMPOUNDS; ANIMALS; ANIMALS, NEWBORN; CARCINOGENS; CODON; CROSSES, GENETIC; DIMETHYL SULFOXIDE; DNA; FEMALE; GENES, RAS; LIVER; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SPECIES SPECIFICITY;

EID: 17044370002     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.20083     Document Type: Article

References (33)

1. Ames BN, Gold LS. Too many rodent carcinogens: Mitogenesis increases mutagenesis. Science 1990;249:970-971.
2. Gaylor DW, Kodell RL, Chen JJ, Krewski D. A unified approach to risk assessment for cancer and noncancer endpoints based on bench mark doses and uncertainty/safety factors. Regul Toxicol Pharmacol 1999;29:151-157.
3. Goodman G, Wilson R. Predicting the carcinogenicity of chemicals in humans from rodent bioassay data. Environ Health Perspect 1991;94:195-218.
4. Parsons BL, Heflich RH. Genotypic selection methods for the direct analysis of point mutations. Mutat Res 1997;387:97-121.
5. Parsons BL, Heflich RH. Detection of a mouse H-ras codon 61 mutation using a modified allele-specific competitive blocker PCR genotypic selection method. Mutagenesis 1998;13:581-588.
6. Reynolds SH, Stowers SJ, Patterson RM, Maronpot RR, Aaronson SA, Anderson MW. Activated oncogenes in B6C3F1 mouse liver tumors: Implications for risk assessment. Science 1987;237:1309-1316.
7. Drinkwater NR, Hanigan MH, Kemp CJ. Genetic determinants of hepatocarcinogenesis in the B6C3F1 mouse. Toxicol Lett 1989;49:255-265.
8. Maronpot RR, Fox T, Malarkey DE, Goldsworthy TL. Mutations in the ras proto-oncogene: Clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology 1995,101:125-156.
9. Manjanatha MG, Li EE, Fu PP, Heflich RH. H- and K-ras mutational profiles in chemically induced liver tumors from B6C3F1 and CD-1 mice. J Toxicol Environ Health 1996;47:195-208.
10. Parsons BL, Culp SJ, Manjanatha MG, Heflich RH. Occurrence of H-rascodon 61 CAAto AAA mutation during mouse liver tumor progression. Carcinogenesis 2002;23:943-948.
11. Flammang TJ, Von Tungeln LS, Kadlubar FF, Fu PP. Neonatal mouse assay for tumorigenicity: Alternative to the chronic rodent bioassay. Regul Toxicol Pharmacol 1997;26:230-240.
12. Anonymous. Overall evaluations of carcinogenicity: An updating of IARC Monographs volumes 1 to 42. IARC Monogr Eval Carcinog Risks Hum - Supplement 1987;7:1-440.
13. Dooley KL, Stavenuiter JF, Westra JG, Kadlubar FF. Comparative carcinogenicity of the food pyrolysis product, 2-amino-5-phenylpyridine, and the known human carcinogen, 4-aminobiphenyl, in the neonatal B6C3F1 mouse. Cancer Lett 1988;41:99-103.
14. Dooley KL, Von Tungeln LS, Bucci T, Fu PP, Kadlubar FF. Comparative carcinogenicity of 4-aminobiphenyl and the food pyrolysates, Glu-P-1, IQ, PhlP, and MelQx in the neonatal B6C3F1 male mouse. Cancer Lett 1992;62:205-209.
15. Von Tungeln LS, Bucci TJ, Hart RW, Kadlubar FF, Fu PP. Inhibitory effect of caloric restriction on tumorigenicity induced by 4-aminobiphenyl and 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhlP) in the CD1 newborn mouse bioassay. Cancer Lett 1996;104:133-136.
16. Von Tungeln LS, Yi P, Bucci TJ et al. Tumorigenicity of chloral hydrate, trichloroacetic acid, trichloroethanol, malondialdehyde, 4-hydroxy-2-nonenal, crotonaldehyde, and acrolein in the B6C3F(1) neonatal mouse. Cancer Lett 2002;185:13-19.
17. Buchmann A, Bauer-Hofmann R, Mahr J, Drinkwater NR, Luz A, Schwarz M. Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: Correlation with susceptibility to hepatocarcinogenesis. Proc Natl Acad Sci USA 1991;88:911-915.
18. Basler J, Hastie ND, Pietras D, Matsui SI, Sandberg AA, Berezney R. Hybridization of nuclear matrix attached deoxyribonucleic acid fragments. Biochemistry 1981;20:6921-6929.
19. Beland FA, Fullerton NF, Heflich RH. Rapid isolation, hydrolysis and chromatography of formaldehyde-modified DNA. J Chromatogr A 1984;308:121-131.
20. Gupta RC. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts. Cancer Res 1985;45:5656-5662.
21. Beland FA, Doerge DR, Churchwell MI, Poirier MC, Schoket B, Marques MM. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard. Chem Res Toxicol 1999;12:68-77.
22. Parsons BL, McKinzie PB, Heflich RH. ACB-PCR detection of rare base substitutions. In: Keohavong P, Grant SG, editors. Molecular toxicology protocols, methods in molecular biology. Totowa, NJ: Humana Press; 2005.
23. Wastl UM, Rossmanith W, Lang MA. et al. Expression of cytochrome P450 2A5 in preneoplastic and neoplastic mouse liver lesions. Mol Carcinog 1998;22:229-234.
24. Kimura S, Kawabe M, Ward JM. et al. CYP1A2 is not the primary enzyme responsible for 4-aminobiphenyl-induced hepatocarcinogenesis in mice. Carcinogenesis 1999;20:1825-1830.
25. Bauer-Hofmann R, Buchmann A, Mahr J, Kress S, Schwarz M. The tumour promoters dieldrin and phenobarbital increase the frequency of c-Ha-ras wild-type, but not of c-Ha-ras mutated focal liver lesions in male C3H/He mice. Carcinogenesis 1992;13:477-481.
26. Stuart GR, Glickman BW. Through a glass, darkly: Reflections of mutation from lacl transgenic mice. Genetics 2000;155:1359-1367.
27. Severin E, Willers R, Bettecken T. Flow cytometric analysis of mouse hepatocyte ploidy. II. The development of polyploidy pattern in four mice strains with different life spans. Cell Tissue Res 1984;238:649-652.
28. McKinzie PB, Delongchamp RR, Heflich RH, Parsons BL. Prospects for applying genotypic selection of somatic onco-mutation to chemical risk assessment. Mutat Res 2001;489:47-78.
29. Gold LS. The carcinogenic potency database (CPDB). Volume 2004. Berkeley, CA: The University of California at Berkeley; 2004, http:/potency.berkeley.edu/ cpdb.html.
30. Bucher JR. The National Toxicology Program rodent bioassay: Designs, interpretations, and scientific contributions. Ann NY Acad Sci 2002;982:198-207.
31. Drinkwater NR, Ginsler JJ, Genetic control of hepatocarcinogenesis in C57BL/6J and C3H/HeJ inbred mice. Carcinogenesis 1986;7:1701-1707.
32. Hanigan MH, Kemp CJ, Ginsler JJ, Drinkwater NR. Rapid growth of preneoplastic lesions in hepatocarcinogen-sensitive C3H/HeJ male mice relative to C57BL/6J male mice. Carcinogenesis 1988;9:885-890.
33. Hanigan MH, Winkler ML, Drinkwater NR. Partial hepatectomy is a promoter of hepatocarcinogenesis in C57BL/6J male mice but not in C3H/HeJ male mice. Carcinogenesis 1990;11:589-594.